No Data
US Stock MarketDetailed Quotes
CDT Conduit Pharmaceuticals
Watchlist
2.280
+0.440+23.91% Close 11/27 16:00 ET
2.2800.0000.00%
Pre 06:44 ET
2.300High1.710Low195.10KVolume
2.000Open1.840Pre Close399.97KTurnover1.07%Turnover RatioLossP/E (TTM)166.02MMarket Cap25.00052wk HighLossP/E (Static)72.81MShares0.95052wk Low-152.00P/B41.41MFloat Cap25.000Historical High--Dividend TTM18.16MShs Float0.950Historical Low--Div YieldTTM32.07%Amplitude2.050Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Conduit Pharmaceuticals Company
Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships. Its medical needs in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in San Diego, CA.
News
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersImpel Pharmaceuticals (NASDAQ:IMPL) shares moved upwards by 141.4% to $0.77 during Thursday's regular session. The market value of their outstanding shares is at $18.4 million. Conduit Pharmace
Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
SAN DIEGO and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (NASDAQ:CDT) ("Conduit Pharmaceuticals" or "Conduit"), a multi-asset clinical-stage disease-agnostic life science company delivering
KXIN and ICU Among Pre-market Losers
Comments
$Conduit Pharmaceuticals(CDT.US$This one im staying away from its a trap
3
$Conduit Pharmaceuticals(CDT.US$ mmm interesting
2
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--